Search Within

Ronald D Finn

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (31)
  3. Conference Paper (5)
Groups
  1. Department of Medicine (69)
  2. GSK Faculty (69)
  3. Hematologic Malignancies, Division of (69)
  4. Molecular Pharmacology and Chemistry Program Faculty (69)
  5. Sloan Kettering Institute Faculty (69)
  6. Radiology, Department of (65)

More Groups

People
  1. Steven Larson (53)
  2. David Scheinberg (52)
  3. Michael Mcdevitt (33)
  4. George Sgouros (28)
  5. Joseph Jurcic (26)
  6. Chaitanya Divgi (25)

More People

Years
  1. 2007 (2)
  2. 2006 (2)
  3. 2005 (3)
  4. 2004 (2)
  5. 2003 (6)
  6. 2002 (4)

More Years

Publications
  1. Journal of Nuclear Medicine (17)
  2. Blood (9)
  3. Applied Radiation and Isotopes (3)
  4. Cancer Biotherapy and Radiopharmaceuticals (3)
  5. Clinical Cancer Research (3)
  6. Journal of Clinical Oncology (3)

More Publications

Publishers
  1. Society of Nuclear Medicine (17)
  2. American Society of Hematology (9)
  3. American Association for Cancer Research (7)
  4. Elsevier Science Inc. (6)
  5. Nature Publishing Group (4)
  6. Pergamon-Elsevier Science Ltd (4)

More Publishers

Results (69)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Divgi, C. R.; Bender, S.; O'Donoghue, J. A.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Slovin, S.; Finn, R.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice
    Journal Article

    McDevitt, M. R.; Chattopadhyay, D.; Jaggi, J. S.; Finn, R. D.; Zanzonico, P. B.; Villa, C.; Rey, D.; Mendenhall, J.; Batt, C. A.; Njardarson, J. T.; more...
    PLoS ONE (2007)

    Fulltext@MSK | Save
  • Alpha-particle immunotherapy for acute myeloid leukemia (AML) with bismuth-213 and actinium-225
    Meeting Abstract

    Jurcic, J. G.; McDevitt, M. R.; Pandit-Taskar, N.; Divgi, C. R.; Finn, R. D.; Sgouros, G.; Apostalidis, C.; Chanel, S.; Larson, S. M.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • [131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: Cell-level dosimetry and dose-dependent toxicity
    Journal Article

    Zanzonico, P.; Koehne, G.; Gallardo, H. F.; Doubrovin, M.; Doubrovina, E.; Finn, R.; Blasberg, R. G.; Riviere, I.; O'Reilly, R. J.; Sadelain, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2006)

    Fulltext@MSK | Save
  • Synthesis and in vitro examination of [(124)I]-, [(125)I]- and [(131)I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitors
    Journal Article

    Veach, D. R.; Namavari, M.; Beresten, T.; Balatoni, J.; Minchenko, M.; Djaballah, H.; Finn, R. D.; Clarkson, B.; Gelovani, J. G.; Bornmann, W. G.; more...
    Nuclear Medicine and Biology (2005)

    Fulltext@MSK | Save
  • Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer
    Journal Article

    Morris, M. J.; Divgi, C. R.; Pandit-Taskar, N.; Batraki, M.; Warren, N.; Nacca, A.; Smith-Jones, P.; Schwartz, L.; Kelly, W. K.; Slovin, S.; more...
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Cyclotron production of cesium radionuclides as analogues for francium-221 biodistribution
    Journal Article

    Finn, R.; Mcdevitt, M.; Sheh, Y.; Lom, C.; Qiao, J.; Cai, S.; Burnazi, E.; Nacca, A.; Pillarsetty, N.; Jaggi, J.; more...
    Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and Atoms (2005)

    Fulltext@MSK | Save
  • Sequential therapy with cytarabine and bismuth-213 (Bi-213)-labeled-HuM195 (anti-CD33) for acute myeloid leukemia (AML)
    Meeting Abstract

    Mulford, D. A.; Pandit-Taskar, N.; McDevitt, M. R.; Finn, R. D.; Weiss, M. A.; Apostolidis, C.; Morgenstern, A.; Divgi, C. R.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Bismuth-labeled anti-CD33 antibody for elimination of minimal residual disease in acute myeloid leukemia
    Meeting Abstract

    Mulford, D.; Divgi, C.; Mcdevitt, M.; Sgouros, G.; Finn, R.; Larson, S.; Apostolidis, C.; Morgenstern, A.; Scheinberg, D.; Jurcic, J.
    Cancer Biotherapy and Radiopharmaceuticals (2004)

    Fulltext@MSK | Save
  • Phase I trial to evaluate J591 as a vascular targeting agent in patients with advanced solid tumors
    Meeting Abstract

    Morris, M. J.; Divgi, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Shaffer, D.; Halpern, J.; Delacruz, A.; Curley, T.; Nacca, A.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save